The Food and Drug Administration has approved a new nonhormonal menopause medication to treat hot flashes. Elinzanetant, which was given the green light Friday under the brand name Lynkuet, belongs to ...
In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel sublingual therapy Tonmya has received approval from the U.S. Food and Drug ...
The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long ...
Flibanserin (Addyi), the drug manufactured by Sprout Pharmaceuticals for the treatment of hypoactive sexual desire disorder (HSDD), received approval from the FDA for use in postmenopausal women up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results